• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化双眼疾病进展之间关系的方法。

Methods to quantify the relation between disease progression in paired eyes.

作者信息

Glynn R J, Rosner B

机构信息

Brigham and Women's Hospital and Harvard Medical School, and Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA.

出版信息

Am J Epidemiol. 2000 May 15;151(10):965-74. doi: 10.1093/oxfordjournals.aje.a010140.

DOI:10.1093/oxfordjournals.aje.a010140
PMID:10853635
Abstract

The authors compared, in the context of diabetic retinopathy, alternative methods of quantifying the extent to which disease progression in one eye increases the risk of subsequent progression in the other eye. Data were gathered on 478 US patients with insulin-dependent diabetes mellitus who participated in the 1983-1988 Sorbinil Retinopathy Trial and were followed up for a median of 41 months. During that time, diabetic retinopathy progressed in 93 right eyes and 77 left eyes. Crude incidence rates of progression for right eyes were 7.7 times higher after the left eye had progressed and, for left eyes, were 4.4 times higher after the right eye had progressed. In eye-specific proportional hazards models that adjusted for increasing rates of progression over time and for baseline risk factors, the comparable relative risks associated with progression in the other eye were 2.6 (95% confidence interval (CI): 1.5, 4.7) for right eyes and 1.4 (95% CI: 0.72, 2.9) for left eyes. Two alternative proportional hazards models that included data on both eyes and accounted for their correlation produced estimated relative risks of 1.9 (95% CI: 1.2, 2.9) and 2.7 (95% CI: 1.8, 3.5), respectively. The more complex models for joint survival integrate information on both eyes and provide more stable estimates than do separate analyses of right or left eyes.

摘要

在糖尿病视网膜病变的背景下,作者比较了量化一只眼睛疾病进展增加另一只眼睛后续进展风险程度的替代方法。收集了478名美国胰岛素依赖型糖尿病患者的数据,这些患者参加了1983 - 1988年的Sorbinil视网膜病变试验,随访时间中位数为41个月。在此期间,93只右眼和77只左眼出现了糖尿病视网膜病变进展。左眼进展后右眼的粗进展发病率高7.7倍,右眼进展后左眼的粗进展发病率高4.4倍。在针对随时间增加的进展率和基线风险因素进行调整的特定眼睛比例风险模型中,与另一只眼睛进展相关的可比相对风险,右眼为2.6(95%置信区间(CI):1.5,4.7),左眼为1.4(95%CI:0.72,2.9)。两个包含双眼数据并考虑其相关性的替代比例风险模型分别产生的估计相对风险为1.9(95%CI:1.2,2.9)和2.7(95%CI:1.8,3.5)。用于联合生存的更复杂模型整合了双眼信息,比单独分析右眼或左眼能提供更稳定的估计。

相似文献

1
Methods to quantify the relation between disease progression in paired eyes.量化双眼疾病进展之间关系的方法。
Am J Epidemiol. 2000 May 15;151(10):965-74. doi: 10.1093/oxfordjournals.aje.a010140.
2
Determinants of retinopathy progression in type 1 diabetes mellitus.1型糖尿病视网膜病变进展的决定因素。
Am J Med. 1999 Jul;107(1):45-51. doi: 10.1016/s0002-9343(99)00165-5.
3
Multiple imputation to estimate the association between eyes in disease progression with interval-censored data.采用多重填补法利用区间删失数据估计疾病进展中双眼之间的关联。
Stat Med. 2004 Nov 15;23(21):3307-18. doi: 10.1002/sim.1770.
4
Aldose reductase inhibitors and late complications of diabetes.醛糖还原酶抑制剂与糖尿病晚期并发症
Drugs. 1986;32 Suppl 2:43-55. doi: 10.2165/00003495-198600322-00010.
5
Diabetic retinopathy.
J Ky Med Assoc. 1986 Apr;84(4):155-8.
6
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.英国糖尿病视网膜病变电子病历用户组:报告3:基线视网膜病变及临床特征预测糖尿病视网膜病变的进展
Am J Ophthalmol. 2017 Aug;180:64-71. doi: 10.1016/j.ajo.2017.05.020. Epub 2017 May 29.
7
The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.视网膜血管管径与糖尿病视网膜病变的发生率和进展的关系:第十九部分:威斯康星糖尿病视网膜病变流行病学研究
Arch Ophthalmol. 2004 Jan;122(1):76-83. doi: 10.1001/archopht.122.1.76.
8
NIH testing sorbinil to prevent diabetic retinopathy.
JAMA. 1984 Sep 14;252(10):1263.
9
Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathy.
Drugs. 1986;32 Suppl 2:30-5. doi: 10.2165/00003495-198600322-00008.
10
First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.葡萄牙糖尿病视网膜病变的首次发病和进展研究,RETNODIAB 研究:里斯本地区筛查计划的评估。
Ophthalmology. 2015 Dec;122(12):2473-81. doi: 10.1016/j.ophtha.2015.08.004. Epub 2015 Sep 15.

引用本文的文献

1
Paired-eye comparison of endothelial cell density and vault height after implantable collamer lens implantation.植入性 Collamer 透镜植入术后角膜内皮细胞密度和穹窿高度的配对眼比较。
Sci Rep. 2024 Nov 12;14(1):27643. doi: 10.1038/s41598-024-79613-7.
2
Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus.从中间型到晚期年龄相关性黄斑变性的进展率与CFH基因座风险等位基因的数量相关。
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6107-6115. doi: 10.1167/iovs.16-19519.
3
Regression methods when the eye is the unit of analysis.
以眼睛作为分析单位时的回归方法。
Ophthalmic Epidemiol. 2012 Jun;19(3):159-65. doi: 10.3109/09286586.2012.674614.